Protective Effect of Daidzein on Ifosfamide-Induced Neurotoxicity Via Improving Some Selected Oxidative Stress Parameters in Male Rats
DOI:
https://doi.org/10.31351/vol32issSuppl.pp53-60Keywords:
Daidzein, Ifosfamide, Neurotoxicity, Oxidative StressAbstract
In this study, the possible protective effects of daidzein on ifosfamide-induced neurotoxicity in male rats were examined by the determination of changes in selected oxidant–antioxidant markers of male rats’ brain tissue.
Twenty-eight (28) apparently-healthy Wistar male rats weighing (120-150gm) allocated into 4 groups (n=7) were used in this study. Rats orally-administered 1% tween 20 dissolved in distilled water/Control (Group I); rats were orally-administered daidzein suspension (100mg/kg) for 7 days (Group II); rats intraperitoneally-injected with a single dose of ifosfamide (500 mg/kg) (Group III); rats orally-administered for 7 days with the daidzein (100mg/kg) before a single intraperitoneal dose of ifosfamide (500 mg/kg) at day 7 (Group IV). Twenty-four (24) hours after the end of treatment, determination of the malondialdehyde, reduced glutathione, and superoxide dismutase enzyme activity levels in the rats’ brain tissue homogenate were performed; in addition to the histopathological examination of the brain tissues sections. Results showed that the levels of malondialdehyde in brain tissue were significantly-increased (P<0.05) in (Group III/ifosfamide-only) rats compared to such level in the rats’ brain tissue of controls (Group I). Furthermore, the brain tissue level of the malondialdehyde was significantly-decreased (P<0.05) in rats of Group IV (orally-administered DZN prior to IFO) compared to such tissue level in rats of Group III. Moreover, the brain levels of each of the reduced glutathione and the superoxide dismutase enzyme activity were significantly-decreased (P<0.05) in (Group III) compared to each level in those of Group I. Additionally, the brain levels of each of the antioxidant parameters was significantly-increase (P<0.05) in Group IV rats compared to each of these tissue levels in rats of Group III.
As a results, daidzein has a protective effect against ifosfamide-induced neurotoxicity in rats via improving some selected oxidative stress parameters in male rats.
How to Cite
Publication Dates
References
Spencer PS, Lein PJ, Philip Wexler. Encyclopedia of Toxicology 3rd ed.Academic Press;2014.
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010 Jan;37(1):13-25.
Linares S.R., Atienza J.B., Rudilla M.C., Rull P.R., Rodriguez A.C., et al. Severe ifosfamide-induced neurotoxicity: a case report. Pharm. World Sci. 2010; 32 (2): 109–111.
Noujaim J, Constantinidou A, Messiou C, Thway K, Miah A, Benson C, Judson I, Jones RL. Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma. Am J Clin Oncol. 2018 Feb;41(2):147-151.
Fukunaga A, Hyuga M, Iwasaki M, Nakae Y, Kishimoto W, Maesako Y, Arima N. Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients. J Clin Exp Hematop. 2016;56(1):50-4.
Sannu A, Radha R, Mathews A, Padmakumari Mony R, Prahladan A, and James FV. Ifosfamide-Induced Malignancy of Ureter and Bladder. Cureus 2017; 9(8): e1594.
Imtiaz S, and Muzaffar N. Ifosfamide neurotoxicity in a young female with a remarkable response to thiamine. JPMA 2010; 60 (10): 867.
Kettle J.K., Grauer D., Folker T.L., O’Neal N., Henry D.W., et al. Effectiveness of exogenous albumin administration for the prevention of ifosfamide- induced encephalopathy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2010; 30 (8): 812–817.
Jarkowski III A. Possible contribution of aprepitant to ifosfamide-induced neurotoxicity. Am. J. Health. Syst. Pharm. 2008; 65 (23): 2229–31.
Ames B., Lewis L.D., Chaffee S., Kim J., and Morse R. Ifosfamide-induced encephalopathy and movement disorder. Pediatr. Blood Cancer 2010; 54 (4): 624–6.
Ginis Z., Ozturk, G., Albayrak, A., Kurt, S.N., Albayrak, M., et al. Protective effects of caffeic acid phenethyl ester on ifosfamide-induced central neurotoxicity in rats. Toxicol. Ind. Health 2016; 32 (2): 337–43.
Ozturk G., Ginis Z., Kurt S.N., Albayrak A., Bilen S., et al. Effect of alpha lipoic acid on ifosfamide-induced central neurotoxicity in rats. Int. J. Neurosci. 2014; 124 (2): 110–6.
Jones D, and Sies H. Oxidative stress. Encycl Stress 2007; 3:45–8.
Di Cataldo A., Astuto M., Rizzo G., Bertuna G., Russo G, et al. Neurotoxicity during ifosfamide treatment in children. Med. Sci. Monit. 2008;15 (1): CS22–CS25.
Kuzu M., Kandemir F.M., Yildirim S., Kucukler S., Caglayan C., et al. Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed. Pharmacother. 2018; 106: 443–53.
Kim JW, Jin YC, Kim YM, Rhie S, Kim HJ, et al. Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kappaB activation. Life Sci. 2009; 84:227–34.
Dong HL, Tang XY, Deng YY, et al. Urinary equol, but not daidzein and genistein, was inversely associated with the risk of type 2 diabetes in Chinese adults. European Journal of Nutrition. 2020;59(2):719-28.
Glisic M, Kastrati N, Musa J, et al. Phytoestrogen supplementation and body composition in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Maturitas. 2018; 115:74–83.
Turhan N Ö, Bolkan F, Duvan C Í, Ardicoglu Y. The effect of isoflavones on bone mass and bone remodeling markers in postmenopausal women. Turkish Journal of Medical Sciences 2008; 38:145–52.
Krebs E.E, Ensrud K.E, MacDonald R and Wilt T.J. Phytoestrogens for treatment of menopausal symptoms: A systematic review. Obstet.Gynecol. 2004, 104, 824–836.
Vinarov Z, Katev V, Radeva D, Tcholakova S, and Denkov ND. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure. Drug Dev Ind Pharm. 2018; 44(4):677-86.
Tomar A, Kaushik S, Khan SI, et al. The dietary isoflavone daidzein mitigates oxidative stress, apoptosis, and inflammation in CDDP-induced kidney injury in rats: Impact of the MAPK signaling pathway. J Biochem Mol Toxicol. 2020; 34: e22431.
Ibrahim M, Abbas W, Ghalib M, and Al-Shawi N. Neuroprotective Effect of Vinpocetine against Lead Acetate-Instigated Neurotoxicity in Rats by Evaluation Tumor Necrosis Factor-Alpha, Interleukin-1Beta and Interleukin-10. Iraqi J Pharm Sci. 2022; 31(2):129-134.
Ilyas S, Tabasum R, Iftikhar A, Nazir M, Hussain A, et al. Effect of Berberis vulgaris L. root extract on ifosfamide-induced in vivo toxicity and in vitro cytotoxicity. Sci Rep. 2021;11(1):1708.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
